Figure 1
From: Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism
Venn diagram of liver × receptor ligand-responsive genes across four different breast cancer cell lines. Responsive genes were defined as those that were statistically significant (false-discovery rate-corrected P < 0.05) and at least 1.5-fold change in treated cells compared to vehicle-treated controls. ER+, estrogen receptor-positive; ER-, estrogen receptor-negative.